Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix? [comment].

Parker, Edward P K; Desai, Shalini; Marti, Melanie; O'Brien, Katherine L; Kaslow, David C; Kochhar, Sonali; Olayinka, Folake; Cravioto, Alejandro; Nohynek, Hanna; Hombach, Joachim; Wilder-Smith, Annelies (2022). Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix? [comment]. Lancet infectious diseases, 22(4), pp. 438-440. Elsevier 10.1016/S1473-3099(22)00178-5

[img] Text
Parker_LancetInfectDis_2022.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (130kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Wilder-Smith, Annelies

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1473-3099

Publisher:

Elsevier

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

18 Mar 2022 12:04

Last Modified:

05 Dec 2022 16:15

Publisher DOI:

10.1016/S1473-3099(22)00178-5

PubMed ID:

35278358

BORIS DOI:

10.48350/167621

URI:

https://boris.unibe.ch/id/eprint/167621

Actions (login required)

Edit item Edit item
Provide Feedback